No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study

Background: Proton pump inhibitor (PPI) use was reportedly associated with an excess of adverse cardiovascular (CV) events, thus making their systemic effects relevant to public health. PPIs reduce gastric acid secretion, causing increased gastrin release. Gastrin stimulates β-cell neogenesis and en...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruszelnicka, Olga, Kuźma, Marcin, Pena, Iwona Z., Perera, Ian B., Chyrchel, Bernadeta, Wieczorek-Surdacka, Ewa, Surdacki, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599926/
https://www.ncbi.nlm.nih.gov/pubmed/28924374
http://dx.doi.org/10.7150/ijms.19457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599926/
https://www.ncbi.nlm.nih.gov/pubmed/28924374
http://dx.doi.org/10.7150/ijms.19457

Ejemplares similares